Organic Process Research & Development 2003, 7, 828−831
Enzymatic Hydrocyanation of a Sterically Hindered Aldehyde. Optimization of a
Chemoenzymatic Procedure for (R)-2-Chloromandelic Acid
Luuk M. van Langen, Fred van Rantwijk, and Roger A. Sheldon*
Laboratory of Biocatalysis and Organic Chemistry, Delft UniVersity of Technology, Julianalaan 136,
2628 BL Delft, The Netherlands
Abstract:
considerable scope in the synthesis of enantiopure 2-hydroxy-
8
-11
The asymmetric synthesis of (R)-o-chloromandelic acid, a key
intermediate for the anti-thrombotic agent clopidogrel, via the
almond meal catalyzed hydrocyanation of 2-chlorobenzaldehyde
and subsequent acidic hydrolysis was developed into an
industrially viable procedure. The use of a minimum amount
of water consistent with enzyme activity and a slow feed of the
reactants were the keys to obtaining (R)-2-chloromandelonitrile
in a high (98%) yield and satisfactory (90%) enantiomeric
excess. Acidic hydrolysis of the nitrile followed by crystallization
from toluene afforded enantiopure (ee > 99%) (R)-2-chloro-
mandelic acid.
nitriles,
acted with only a modest enantioselectivity (ee
12
83%) in the hydrocyanation of 2-chlorobenzaldehyde.
This latter reaction was carried out in an aqueous-organic
two-phase solvent system, which is a proven concept for the
enzymatic synthesis of cyanohydrins. In such a reaction
system, the enzyme resides in the aqueous (working) phase
and the reactants and products reside in the organic (extrac-
tive) phase. The resulting low reactant concentration in the
aqueous phase suppresses the competing uncatalyzed back-
1
3
ground reaction, which otherwise would erode the enan-
tioselectivity. Additionally, the pH is maintained in the acidic
14
range to reduce the rate of the nonenzymatic reaction. Such
systems perform quite satisfactorily with a wide range of
aldehydes, and a computer model that predicts the final
conversion and enantiomeric excess has been constructed.1
Alternatively, the reaction can be conducted in a mi-
croaqueous organic phase, in combination with almond
Introduction
Enantiopure 2-hydroxycarboxyxlic acids are useful chiral
intermediates and building blocks. Thus, (R)-2-(2-chlorophen-
yl)-hydroxyacetic acid ((R)-o-chloromandelic acid) is emerg-
ing as the preferred chiral intermediate for the industrial
synthesis of the anti-thrombotic agent clopidogrel. Resolu-
tion procedures for (R)-o-chloromandelic acid include dia-
stereomeric crystallization2 and enantioselective enzymatic
5,16
1
7-19
meal,
which is the cheapest possible immobilisate of
1
almond oxynitrilase. We decided to investigate the scope of
such systems in the enzymatic hydrocyanation of 2-chlo-
robenzaldehyde. We now report the development of an
efficient chemoenzymatic route to (R)-o-chloromandelic acid.
-4
5
hydrolyis of the corresponding nitrile. Such resolution
procedures generally require the racemization of the un-
desired enantiomer. In the case of o-chloromandelic acid,
this can be accomplished in aqueous alkaline DMSO at 100
Results and Discussion
A baseline case was established by comparing the
enzymatic hydrocyanation of benzaldehyde (1) and 2-chlo-
robenzaldehyde (2) in a diisopropyl ether-water (50:50, v/v)
biphasic medium. Whereas 1 was rapidly converted into (R)-
mandelonitrile (3, ee > 99%), 2 reacted quite sluggishly at
°C. (R)-o-Chloromandelic acid has also been synthesized via
asymmetric transformations, which do not suffer from this
latter drawback. These include a microbial reduction of 2-(2-
chlorophenyl)-glyoxylic acid and the asymmetric addition
of trimethylsilyl cyanide to 2-chlorobenzaldehyde in the
presence of a chiral transition metal complex.7
6
(
8) Brussee, J.; Van der Gen, A. Biocatalysis in the Enantioselective Formation
of Chiral Cyanohydrins, Valuble Building Blocks in Organic Synthesis. In
StereoselectiVe Biocatalysis; Patel, R. N., Ed.; Dekker: New York, 2000;
pp 289-320.
The (R)-specific oxynitrilase from almonds (hydroxynitrile
lyase from Prunus amygdalus, E.C. 4.1.2.10), which has
*
Corresponding author. Roger A. Sheldon, Laboratory of Organic Chemistry
(9) Effenberger, F. Hydroxynitrile Lyases in Stereoselective Synthesis. In
StereoselectiVe Biocatalysis; Patel, R. N., Ed.; Dekker: New York, 2000;
pp 321-342.
(10) Schmidt, M.; Griengl, H. Top. Curr. Chem. 1999, 200, 193-226.
(11) North, M. Tetrahedron: Asymmetry 2003, 14, 147-176.
(12) Kirschbaum, B.; Wilbert, G.; Effenberger, F. U.S. Patent 2,002,052,523,
2002; Chem. Abstr. 2002, 136, 355075.
(13) Loos, W. T.; Geluk, H. W.; Ruijken, M. M. A.; Kruse, G. C.; Brussee, J.;
Van der Gen, A. Biocatal. Biotransform. 1995, 12, 255-266.
(14) Niedermeyer, U.; Kula, M. R. Angew. Chem., Int. Ed. Engl. 1990, 29, 386-
387.
(15) Willeman, W. K.; Straathof, A. J. J.; Heijnen, J. J. Enzyme Microb. Technol.
2002, 30, 200-208.
(16) Willeman, W. F.; Gerrits. P. J.; Hanefeld, U.; Brussee, J.; Straathof, A. J.
J.; Van der Gen, A.; Heijnen, J. J. Biotechnol. Bioeng. 2002, 77, 239-247.
(17) Zandbergen, P.; Van der Linden, J.; Brussee, J.; Van der Gen, A. Synth.
Commun. 1991, 21, 1387-1391.
(18) Kiljunen, E.; Kanerva, L. T. Tetrahedron: Asymmetry 1996, 7, 1105-1116.
(19) Lin, G.; Han, S.; Li, Z. Tetrahedron: Asymmetry 1998, 9, 1835-1838.
and Catalysis, Delft University of Technology, Julianalaan 136, 2628 BL Delft,
The Netherlands. Telephone: + 31 15 278 2683. Fax: + 31 15 278 1415.
E-mail: R. A.Sheldon@tnw.tudelft.nl.
(1) Bousquet, A.; Musolino, A. PCT Int. Appl. WO 9918110, 1999; Chem.
Abstr. 1999, 130, 296510e.
(
(
(
(
2) Noda, H.; Sakai, K.; Murakami, N. Jpn. Kokai Tokkyo Koho JP 2001072664,
2
001; Chem. Abstr. 2001, 134, 237304a.
3) Hyoda, T.; Nawata, H. Jpn. Kokai Tokkyo Koho JP 2002114737 2002;
Chem. Abstr. 2002, 136, 309759.
4) Balint, J.; Csatarine Nagy, M.; Dombrady, Z.; Fogassy, E.; Gajari, A.; Suba,
C. PCT Int. Appl. WO 0300636, 2003; Chem. Abstr. 2003, 136, 309759.
5) De Santis, G.; Zhu, Z.; Greenberg, W. A.; Wong, K.; Chaplin, J.; Hanson,
S. R.; Fanwell, B.; Nicholson, L. W.; Rand, C. L.; Weiner, D. P.; Robertson
D. E.; Burk, M. J. J. Am. Chem. Soc. 2002, 124, 9024-9025.
6) Mitsuhashi, K.; Yamamoto, H. Eur. Pat. Appl. EP 1316613, 2003; Chem.
Abstr. 2003, 139, 5772.
(
(
7) Blacker, A. J.; Houson, I. N. PCT Int. Appl. WO 0266410, 2002; Chem.
Abstr. 2002, 137, 201079.
8
28
•
Vol. 7, No. 6, 2003 / Organic Process Research & Development
10.1021/op0340964 CCC: $25.00 © 2003 American Chemical Society
Published on Web 09/12/2003